| Target
Information |
| Name | 5-hydroxytryptamine 2 receptor |
| Type of target | Successful target |
| Synonyms | 5-HT2 receptor |
| 5-HTB2 |
| Serotonin receptor 2 |
| Disease | Acute respiratory distress syndrome [1][2] |
| Cocaine dependence [3][4] |
| Detrusor hyperreflexia [5] |
| Hypertension [2][6][7] |
| Skeletal muscle associated spasticity [8] |
| Urinary incontinence [5] |
| Drug(s) | Cyclobenzaprine |  | Approved | Depression | [9] |
| Ketanserin |  | Approved | Hypertension | [10] |
| Mianserin |  | Approved | Depression | [11][12][13][3] |
| Fluphenazine Decanoate |  | Phase II | Psoriasis | [14] |
| E2101 |  | Phase I | Cervical dystonia | [8] |
| BioChemical Class | G-protein coupled receptor (rhodopsin family) |
| Pathway | Calcium signaling pathway |
| Gap junction |
| Neuroactive ligand-receptor interaction |
| Related US Patent | 6,469,011 |
| 6,638,934 |
| 6,664,286 |
| Target Validation | Click to Find Target Validation Information. |
| Antagonist | Cyclobenzaprine |  | [9] |
| E2101 |  | [8] |
| Fluphenazine Decanoate |  | [14] |
| Ketanserin |  | [10] |
| Metrenperone |  | [15][16][17][1] |
| Mianserin |  | [11][12][13][3] |
| Ritanserin |  | [18][19][20][6] |
| Binder | SB 206553 hydrochloride |  | [21] |
| Multitarget | Fluphenazine Decanoate |  | [14] |
| Cross References |
3D Structure
Related Literature
On-Line
Medical Dictionary |
| Ref 1 | Efficiency of 5-hydroxytryptamine receptor blockade as therapeutic measure during acute respiratory distress syndrome in double-muscled cattle. Zentralbl Veterinarmed A. 1993 Apr;40(3):185-93. To Reference |
| Ref 2 | The use of ketanserin, a 5-hydroxytryptamine receptor antagonist, for treatment of postoperative hypertension following coronary artery bypass surgery. Anesth Analg. 1983 Jan;62(1):63-9. To Reference |
| Ref 3 | 5-HT2 receptor antagonists given in the acute withdrawal from daily cocaine injections can reverse established sensitization. Eur J Pharmacol. 2002 Oct 25;453(2-3):255-63. To Reference |
| Ref 4 | Antagonism of 5-hydroxytryptamine(2a) receptors attenuates the behavioral effects of cocaine in rats. J Pharmacol Exp Ther. 2001 Apr;297(1):357-63. To Reference |
| Ref 5 | Influence of central serotonergic mechanisms on lower urinary tract function. Urology. 2002 May;59(5 Suppl 1):30-6. To Reference |
| Ref 6 | Combined treatment of portal hypertension with ritanserin and propranolol in conscious and unrestrained cirrhotic rats. Hepatology. 1992 May;15(5):878-82. To Reference |
| Ref 7 | 5-Hydroxytryptamine receptor activity of the dopamine receptor agonist fenoldopam in canine tracheal smooth muscle. J Pharmacol Exp Ther. 1992 Feb;260(2):491-8. To Reference |
| Ref 8 | In vitro interactions between a potential muscle relaxant E2101 and human cytochromes P450. Drug Metab Dispos. 2002 Jul;30(7):805-13. To Reference |
| Ref 9 | Torticollis under Cyclobenzaprine. Pharmacology. 2009 Jul 8;84(2):91-92. [Epub ahead of print] To Reference |
| Ref 10 | Nordexfenfluramine causes more severe pulmonary vasoconstriction than dexfenfluramine. Am J Physiol Lung Cell Mol Physiol. 2004 Mar;286(3):L531-8. Epub 2003 Nov 7. To Reference |
| Ref 11 | 5-HT reuptake and 5-HT2 receptors modulate capsaicin-evoked hypothermia in rats. Neurosci Lett. 2008 Jan 17;430(3):191-6. Epub 2007 Nov 5. To Reference |
| Ref 12 | 5-HT2 and 5-HT3 receptors in the lateral parabrachial nucleus mediate opposite effects on sodium intake. Neuroscience. 2007 Jun 8;146(4):1453-61. Epub 2007 Apr 16. To Reference |
| Ref 13 | Lack of effect of some dopamine and non-dopamine receptor ligands on amphetamine-induced changes in the rat brain neuropeptide Y system. Pharmacol Rep. 2005 Nov-Dec;57(6):850-5. To Reference |
| Ref 14 | Emerging drugs for psoriasis. Expert Opin Emerg Drugs. 2009 Mar;14(1):145-63. To Reference |
| Ref 15 | Cardiovascular response to intravenous administration of 5-hydroxytryptamine after type-2 receptor blockade, by metrenperone, in healthy calves. Vet J. 1999 Jan;157(1):31-7. To Reference |
| Ref 16 | Pulmonary response to intravenous administration of 5-hydroxytryptamine after type-2 receptor blockade in healthy calves. Am J Vet Res. 1993 Jan;54(1):168-73. To Reference |
| Ref 17 | Induction of serotonin-S2 receptor blockade during early or late stage of acute respiratory distress syndrome in double-muscled calves: a comparative study. Zentralbl Veterinarmed A. 1993 May;40(4):241-8. To Reference |
| Ref 18 | Characterization of contractile 5-hydroxytryptamine receptor subtypes in the in situ autoperfused kidney in the anaesthetized rat. Eur J Pharmacol. 2008 Sep 11;592(1-3):133-7. Epub 2008 Jul 4. To Reference |
| Ref 19 | Hypersensitivity of 5-HT2 receptors in OCD patients. An increased prolactin response after a challenge with meta-chlorophenylpiperazine and pre-treatment with ritanserin and placebo. J Psychiatr Res. 2008 Sep;42(11):894-901. Epub 2008 Jun 3. To Reference |
| Ref 20 | Effects of antipsychotics and reference monoaminergic ligands on marble burying behavior in mice. Behav Pharmacol. 2008 Mar;19(2):145-52. To Reference |
| Ref 21 | Evidence for the preferential involvement of 5-HT2A serotonin receptors in stress- and drug-induced dopamine release in the rat medial prefrontal cortex. Neuropsychopharmacology. 2006 Feb;31(2):265-77. To Reference |